Bristol-Myers Squibb Co
BMY:NYSE
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 43.30 | 0.53 1.24% | 3.23% | 11,130,086 | 13.2M |
Market data is delayed by at least 20 minutes.
5/18/2013 6:06 AM ET
| Market Comparison | P/E (TTM) | P/E (Forward 12 Months) | PEG | 1 Year EPS Growth Rate | 5 Year EPS Growth Rate |
| BMY Bristol-Myers Squibb Co | 49.4 | 35.1 | 5.2 | -46.16% | 12.31% |
| Biotechnology & Drugs Industry | 51.8 | 16.0 | 3.5 | 12.15% | 8.06% |
| Healthcare Sector | 24.9 | 17.8 | 4.1 | -48.30% | 6.80% |
| S&P; 500 | 18.1 | 18.9 | 3.6 | -3.64% | 6.28% |
Earnings Summary
On 4/25/2013, BMY reported 1 quarter 2013 earnings of $0.41 per share. This result was in-line with the consensus of the 14 analysts following the company and missed last year's 1 quarter results by 35.94%.
BMY's PE ratio is among the highest of any stock in the Biotechnology & Drugs industry and signals that investors have high hopes for this company's future business prospects. However, during the past year, earnings growth has lagged its historical five year growth rate.